Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals Max Drawdown (5Y) : 69.88% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 69.88% |
| September 30, 2026 | 69.88% |
| August 31, 2026 | 69.88% |
| July 31, 2026 | 69.88% |
| June 30, 2026 | 69.88% |
| May 31, 2026 | 69.88% |
| April 30, 2026 | 69.88% |
| March 31, 2026 | 69.88% |
| February 28, 2026 | 69.88% |
| January 31, 2026 | 69.88% |
| December 31, 2025 | 69.88% |
| November 30, 2025 | 69.88% |
| October 31, 2025 | 69.88% |
| September 30, 2025 | 69.88% |
| August 31, 2025 | 69.88% |
| July 31, 2025 | 69.88% |
| June 30, 2025 | 69.29% |
| May 31, 2025 | 69.12% |
| April 30, 2025 | 63.70% |
| March 31, 2025 | 60.70% |
| February 28, 2025 | 60.70% |
| January 31, 2025 | 60.70% |
| December 31, 2024 | 61.18% |
| November 30, 2024 | 61.18% |
| October 31, 2024 | 61.18% |
| Date | Value |
|---|---|
| September 30, 2024 | 68.30% |
| August 31, 2024 | 68.30% |
| July 31, 2024 | 68.30% |
| June 30, 2024 | 68.30% |
| May 31, 2024 | 68.30% |
| April 30, 2024 | 68.30% |
| March 31, 2024 | 71.40% |
| February 29, 2024 | 73.15% |
| January 31, 2024 | 73.15% |
| December 31, 2023 | 75.13% |
| November 30, 2023 | 78.98% |
| October 31, 2023 | 78.98% |
| September 30, 2023 | 78.98% |
| August 31, 2023 | 78.98% |
| July 31, 2023 | 78.98% |
| June 30, 2023 | 78.98% |
| May 31, 2023 | 78.98% |
| April 30, 2023 | 78.98% |
| March 31, 2023 | 78.98% |
| February 28, 2023 | 78.98% |
| January 31, 2023 | 78.98% |
| December 31, 2022 | 78.98% |
| November 30, 2022 | 78.98% |
| October 31, 2022 | 78.98% |
| September 30, 2022 | 78.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Emergent BioSolutions, Inc. | 98.89% |
| Incyte Corp. | 58.51% |
| Vertex Pharmaceuticals, Inc. | 40.15% |
| Travere Therapeutics, Inc. | 83.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -14.63 |
| Beta (5Y) | 0.4800 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.28% |
| Historical Sharpe Ratio (5Y) | -0.19 |
| Historical Sortino (5Y) | -0.4038 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.67% |